| Stage | ABBV | % of rev | ABT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.0B | 100.00% | $12.6B | 100.00% | ABBV ×1.35 |
| Gross profit | $12.4B | 73.03% | $7.3B | 57.71% | ABBV +15.3pp |
| Operating income | $6.4B | 37.86% | $1.7B | 13.44% | ABBV +24.4pp |
| Pre-tax income | $4.3B | 25.18% | $1.5B | 12.10% | ABBV +13.1pp |
| Net income | $3.6B | 21.28% | $928M | 7.37% | ABBV +13.9pp |
| Stage | ABBV | ABT | Gap · A − B |
|---|---|---|---|
| Revenue | $17.0B100.00% | $12.6B100.00% | ABBV ×1.35 |
| Gross profit | 73.03%$12.4B | 57.71%$7.3B | ABBV +15.3pp |
| Operating income | 37.86%$6.4B | 13.44%$1.7B | ABBV +24.4pp |
| Pre-tax income | 25.18%$4.3B | 12.10%$1.5B | ABBV +13.1pp |
| Net income |
| 21.28%$3.6B |
| 7.37%$928M |
| ABBV +13.9pp |
No shared counterparties.